8-K: Cambium Networks Faces Nasdaq Delisting

Cambium Networks Corporation announced its ordinary shares will be delisted from Nasdaq due to non-compliance, with trading suspended on March 27, 2026.

Summary

• Cambium Networks Corporation received a notice on March 25, 2026, from the Nasdaq Hearings Panel regarding the delisting of its ordinary shares from The Nasdaq Stock Market.
• The delisting is due to the Company's failure to comply with the terms of the Panel's December 3, 2025 decision, which required adherence to milestones for filing periodic reports with the Securities and Exchange Commission.
• Trading in the Company's ordinary shares on Nasdaq will be suspended at the open of trading on March 27, 2026.
• The Company is considering an appeal to the Nasdaq Listing and Hearing Review Council, but such a request would not prevent the trading suspension.
• Ordinary shares are expected to be immediately eligible for quotation on the OTCID market (OTC Markets) under the trading symbol CMBM, initially on the OTC Pink Limited tier and then the Expert Market.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative development, as delisting from Nasdaq due to non-compliance significantly impairs the company's market standing, liquidity, and investor confidence.

Positives

• The Company is considering an appeal to the Nasdaq Listing and Hearing Review Council, indicating an effort to reverse the decision.
• Ordinary shares are expected to be immediately eligible for quotation on the OTCID market, providing a continued venue for trading.

Negatives

• Delisting from The Nasdaq Stock Market due to non-compliance with listing rules.
• Trading in ordinary shares will be suspended on Nasdaq at the open of trading on March 27, 2026.
• Trading on the OTCID market may have a material adverse effect on the trading price and volume for the Ordinary Shares.
• Investors may experience reduced liquidity, less transparency, and greater price volatility on the OTC markets.
• There is no assurance that a market for the Ordinary Shares will develop or be maintained on the OTCID market.
• Shareholders may find it more difficult to buy or sell their shares.

Risks

• The Company's ability to successfully appeal the Delist determination.
• Material adverse effect on the trading price and volume for the Ordinary Shares due to trading on the OTCID market.
• No assurance that a market for the Ordinary Shares will develop or be maintained on the OTCID market.
• Reduced liquidity, less transparency, and greater price volatility for investors on OTC markets.
• Difficulty for shareholders to buy or sell their shares on the OTCID market.
• The ability to return to Nasdaq and maintain compliance with Nasdaq continued listing standards.

Future Outlook

The Company is considering whether to request an appeal of the delisting determination to the Nasdaq Listing and Hearing Review Council. Trading in the Company's ordinary shares is expected to be suspended from Nasdaq on March 27, 2026, and will likely move to the OTCID market, initially on the OTC Pink Limited tier and then the Expert Market. The Company acknowledges that trading on the OTCID market may have a material adverse effect on trading price and volume, and there is no assurance a market will develop or be maintained.

Management Comments

• "The Company is considering whether to request an appeal of the Delist Determination to the Nasdaq Listing and Hearing Review Council."

Industry Context

StockSavvy.ai notes that delistings from major exchanges like Nasdaq typically occur when companies fail to meet stringent listing requirements, often related to financial reporting timeliness or minimum share price. Such events can severely impact investor confidence and a company's ability to raise capital, placing it at a significant disadvantage compared to peers that maintain exchange compliance. The move to OTC markets is a common consequence, but it often entails reduced visibility and liquidity, which can further depress valuation.

Stakeholder Impact

• Shareholders will experience reduced liquidity, less transparency, greater price volatility, and potentially a material adverse effect on the trading price and volume of their shares. They may find it more difficult to buy or sell shares.
• Company (Management/Employees) faces reputational damage, potential difficulty in attracting and retaining talent, and increased scrutiny.
• Creditors may view the company as higher risk due to governance issues and reduced market access, potentially impacting future financing terms.

Next Steps

• The Company is considering whether to request an appeal of the Delist Determination to the Nasdaq Listing and Hearing Review Council.
• Trading in the Company's ordinary shares will be suspended from Nasdaq at the open of trading on March 27, 2026.
• The Company expects its ordinary shares to be immediately eligible for quotation on the OTCID market.

Key Dates

Recommendation

The delisting from Nasdaq due to non-compliance with reporting requirements is a severe negative event, indicating significant operational and governance issues. The move to the OTC market will drastically reduce liquidity, transparency, and likely lead to substantial price volatility and a material adverse effect on share value. The uncertainty of an appeal and the inherent difficulties of trading on OTC markets make this a high-risk investment with significant downside potential.

Keywords

Cambium Networks, CMBM, Nasdaq, delisting, OTC Markets, stock suspension, non-compliance, financial reporting, corporate governance, equity trading